Title of article :
Gemcitabine, Cisplatin and Dexamethasone in Patients with Recurrent or Refractory B-Cell Lymphoma Not Candidates for High-Dose Therapy
Author/Authors :
SAAD, MOHAMAD Mansoura University - Faculty of Medicine - Department of Clinical Oncology Nuclear Medicine, Egypt , AWAD, IMAN Mansoura University - Faculty of Medicine - Department of Clinical Oncology Nuclear Medicine, Egypt , ABO-TOUK, NIVEEN Mansoura University - Faculty of Medicine - Department of Clinical Oncology Nuclear Medicine, Egypt , AL-DEIN, MANAL SALLAH Mansoura University - Faculty of Medicine - Oncology Center, Egypt
Abstract :
Background: High dose therapy (HDT) with autologous stem-cell transplantation is the treatment of choice for patients with relapsed lymphoma, but is not appropriate for all patients. Effective and less toxic alternatives to conventional salvage regimens are needed.
Keywords :
Gemcitabine , Cisplatin , Recurrent , Refractory Lymphoma.
Journal title :
The Medical Journal of Cairo University
Journal title :
The Medical Journal of Cairo University
